Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions
MedComm · 2026-08 · 7 (8)
DOI: 10.1002/mco2.70869 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 17.07.2026. Verfasst von Mowei Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The Affiliated Hospital of Southwest Medical University Luzhou Sichuan Province China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, and the burden is particularly severe in low‐income and middle‐income countries. Although traditional risk factors such as hypertension, dyslipidemia, diabetes, and smoking have been well established, new research evidence indicates that inflammation, environmental exposure, psychological and social stress, gut microbiota, and genetic susceptibility play a crucial role in shaping the risk profile of CVDs. This review comprehensively summarizes the epidemiology, pathophysiological mechanisms, screening strategies, prevention, and treatment interventions of CVDs throughout the disease development process. Special emphasis is placed on the integration of multiomics methods, artificial intelligence (AI), and digital health technologies (including wearable devices and AI‐enhanced electrocardiograms), which are transforming risk prediction and personalized prevention approaches. We also summarize current preclinical and clinical evidence, including ongoing trials, and discuss implementation differences in different socioeconomic environments. Despite significant progress, there are still many challenges in translating new biomarkers and technologies into scalable and equitable clinical applications. This review identifies key knowledge gaps and proposes future directions toward precision cardiovascular medicine, aiming to combine mechanistic insights with practical applications, ultimately reducing the burden of CVDs globally.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology The Affiliated Hospital of Southwest Medical University Luzhou Sichuan Province China.
- Department of Cardiology Panzhihua Central Hospital Panzhihua Sichuan China.
- Key Laboratory of Medical Electrophysiology Institute of Cardiovascular Research Ministry of Education Luzhou Sichuan Province China.
- Basic Medicine Research Innovation Center For Cardiometabolic Diseases Ministry of Education Southwest Medical University Luzhou Sichuan Province China.
- Nucleic Acid Medicine of Luzhou Key Laboratory Luzhou Sichuan China.
ORCID-Profile: Zaiyong Zheng, Chunxiang Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kong, M., Zheng, Z., Huang, M., Huang, S., Zhao, X., Yu, Y., & Zhang, C. (2026). Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions. MedComm, 7(8). https://doi.org/10.1002/mco2.70869
Vancouver
Kong M, Zheng Z, Huang M, Huang S, Zhao X, Yu Y, et al. Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions. MedComm. 2026;7(8). doi:10.1002/mco2.70869
BibTeX
@article{Kong2026,
author = {Kong, Mowei and Zheng, Zaiyong and Huang, Min and Huang, Shengyu and Zhao, Xingwei and Yu, Yang and Zhang, Chunxiang},
title = {Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions},
journal = {MedComm},
year = {2026},
volume = {7},
number = {8},
doi = {10.1002/mco2.70869}
}
EUVIMED